HESTERBIOBSEHester Biosciences LtdMediumNeutral
Announced Fri, 15 May · 12:25 IST

Disclosure on Board Approval for re-classification requests under Regulation 31A of SEBI Listing Regulations

Promoter Stake Sell 1pctOwnership Changes View source PDF

HESTERBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.6%1-day move
₹1749.00
prior close
₹1947.50
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.6+0.6+0.5+0.1+1.6+3.8+5.2+7.8+8.2+21.8+11.7+18.8+37.4
Up moveDown movePending
AI summary

The Board of Directors of Hester Biosciences has approved the re-classification of Mr. Ravin Gandhi and Ms. Bela Gandhi from the 'promoter' category to 'public' category shareholders. These two individuals, who are part of the Promoter group, have submitted requests for this change. The Board has approved submission of the application to BSE and NSE for obtaining a No Objection Certificate. The applicants have confirmed they satisfy the conditions specified under Regulation 31A(3)(b) of SEBI LODR Regulations. The re-classification remains subject to approval from the Stock Exchanges.

Likely market impact

When promoters request re-classification to public shareholders, it typically indicates they are reducing their promoter stake or intent to sell shares. This may lead to dilution of promoter holding and increased public shareholding in the company.